热门资讯> 正文
Sangamo Therapeutics 2024年第二季度GAAP每股收益$（0.18）错过$（0.16）估计，销售额356.000 K美元错过826万美元估计
2024-08-07 05:29
Sangamo Therapeutics (NASDAQ: SGMO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. The company reported quarterly sales of $356.000 thousand which missed the analyst consensus estimate of $8.260 million by 95.69 percent. This is a 94.79 percent decrease over sales of $6.835 million the same period last year.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
